Leveraging Immunopeptidomics To Study and Combat Infectious Disease

Area of Science:

• Immunology
• Vaccinology
• Proteomics

Background:

• T cells recognize pathogen peptides presented by major histocompatibility complexes (MHCs) to mount immune responses.
• Identifying these presented antigens is key for developing effective vaccines against infections.
• Professional antigen-presenting cells (APCs) play a crucial role in initiating adaptive immunity.

Purpose of the Study:

• To review the role of immunopeptidomics in understanding antigen presentation during infection.
• To highlight how immunopeptidomic studies contribute to T cell priming knowledge.
• To explore the potential of immunopeptidomics in guiding vaccine development for infectious diseases.

Main Methods:

• Immunopeptidomics, utilizing mass spectrometry, enables whole-proteome scale identification of peptides bound to MHCs.
• This technique analyzes antigens presented by infected cells and professional APCs.
• The review synthesizes findings from various immunopeptidomic studies.

Main Results:

• Immunopeptidomics has significantly advanced the understanding of antigen presentation in infectious contexts.
• The technique has identified numerous potential vaccine targets from various pathogens.
• Studies demonstrate the link between identified antigens and T cell responses.

Conclusions:

• Immunopeptidomics is a powerful tool for discovering vaccine candidates against infectious diseases.
• This approach aids in understanding T cell priming mechanisms during infection.
• Further application of immunopeptidomics holds promise for global health by informing novel vaccine strategies.